Be part of the Startup Valencia community made up of 48,000+ professionals
Tetraneuron

Tetraneuron is a drug discovery company, focused on the development of a disruptive Gene Therapy for Alzheimer’s disease (AD) and an Early Biomarker for this neurodegenerative condition.

Locations
Year of foundation
2012
Funding Stage
Series A (from 1 to less than 5 M EUR)
Number of employees
2-10
Targets
Categories

Working together makes us stronger

Join us